Equivalent of Carbon Dioxide at the Anaerobic Threshold Predicts Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
Authors:
- Yunxiao LiYLYunxiao Li
- Xiaona LiXLXiaona Li
- Fang LinFLFang Lin
- Xing HuXHXing Hu
- Siqi LiuSLSiqi Liu
- Mengmeng QiuMQMengmeng Qiu
- Jianxiong ZhangJZJianxiong Zhang
- Ranran ZhaoRZRanran Zhao
- Shan NieSNShan Nie
- Bo XuBXBo Xu
- Fugui YanFYFugui Yan
- Ganggang YuGYGanggang Yu
Open Access
- 1 May 2026
- journal article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-13
Abstract
To investigate the predictive value of the equivalent of carbon dioxide at the anaerobic threshold (EqCO2@AT) for acute exacerbations (AE) in patients with chronic obstructive pulmonary disease (COPD). This retrospective cohort study included 79 patients with COPD who underwent baseline pulmonary function testing and cardiopulmonary exercise testing (CPET). EqCO2@AT = 30 was used only as an empirical threshold for descriptive stratification, rather than as an outcome-derived cutoff. Patients were also classified into non-AE and AE groups according to annualized exacerbation frequency. Baseline characteristics, pulmonary function, and CPET parameters were compared between groups. Logistic regression was used to evaluate the association between EqCO2@AT and AE risk. Predictive performance was assessed using receiver operating characteristic curves, calibration analysis, decision curve analysis, Kaplan–Meier analysis, and a simplified nomogram. Of the 79 patients, 16 were classified into the low EqCO2@AT group and 63 into the high EqCO2@AT group. Patients with higher EqCO2@AT were older, had lower BMI, greater smoking exposure, lower FEV1% predicted and DLCO% predicted, reduced exercise capacity, and higher ventilatory inefficiency parameters. Compared with the non-AE group, the AE group had worse lung function, lower exercise capacity, and higher VE/VCO2 slope and EqCO2@AT. EqCO2@AT was associated with AE risk in univariable analysis (OR 1.122, 95% CI 1.027–1.226, P = 0.011) and remained significant after adjustment for age, BMI, and FEV1% predicted (OR 1.269, 95% CI 1.110–1.450, P < 0.001). The AUC of EqCO2@AT alone was 0.739, whereas the combined model achieved an AUC of 0.850. Kaplan–Meier analysis showed significantly lower AE-free survival in the high EqCO2@AT group (log-rank P = 0.002). The simplified nomogram provided an individualized visual tool for AE risk estimation. Elevated EqCO2@AT is associated with impaired ventilatory efficiency, reduced exercise capacity, and increased AE risk in COPD. A model incorporating EqCO2@AT, age, BMI, and FEV1% predicted showed good predictive performance and may support individualized AE risk stratification. These findings suggest that CPET-derived ventilatory efficiency parameters may provide clinically useful information beyond conventional pulmonary function assessment, although validation in larger multicenter prospective cohorts is still required.Keywords
This publication has 20 references indexed in Scilit:
- Frequency and severity of COPD exacerbations and future risk of exacerbations and mortality: an observational cohort study in CanadaBMJ Open Respiratory Research, 2025
- Activity-related dyspnea and exercise intolerance in chronic obstructive pulmonary disease: recent insightsCurrent Opinion in Pulmonary Medicine, 2024
- Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in JapanAdvances in Therapy, 2024
- Prevalence and prognostic importance of exercise limitation and physical inactivity in COPDBreathe, 2024
- Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2024
- Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practiceCurrent Opinion in Pulmonary Medicine, 2023
- Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory DiseaseChest, 2022
- Impact of Body Mass Index Change on the Prognosis of Chronic Obstructive Pulmonary DiseaseRespiration, 2020
- ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseasesEuropean Respiratory Review, 2019
- Chronic Obstructive Pulmonary DiseaseClinics in Chest Medicine, 2014